Unlocking the Therapeutic Potential of Previously Undruggable Peptidergic GPCRs

Time: 11:15 am
day: Day Two

Details:

  • Orion’s platform introduces efficiencies to GPCR discovery
  • Developing novel molecules with optimized characteristics for drugging peptidergic GPCRs
  • Diversified portfolio of preclinical and clinical programs
  • AI integration for data-driven pipeline expansion

Speakers: